Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Air Liquide Santé International
With
Euraxi Pharma
This study is intended to describe daily practice and therefore, there is not a standardized protocol but only patient-based and site-based questionnaires.
Age
0–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Newborn \> or = to 34 weeks gestational age suffering from hypoxic respiratory failure with pulmonary hypertension (France only) or patient presenting post-operative pulmonary hypertension associated with cardiac surgery (France and Belgium) · Patient treated with iNO delivered with EZ-KINOX™
You may not be if
Newborn dependent on a right-to-left shunt or with a "malignant" left-right arterial canal
Newborn with Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency.
Clareo Health | Study on the Use of Inhaled NO (iNO)
